Coronavirus Update: Roche's Actemra Fails In Phase III COVID Study

Plus: Favipiravir Market Heating Up In India

29 Jul 2020

• By Scrip Team

Disappointment as Roche/Chugai antibody tocilizumab misses most endpoints.

Stewardess — Spain's hopes of reviving its tourism industry have been hit by a spike in new COVID-19 cases. The UK and Germany have both warned their citizens to stay away or face quarantine measures on their return.

More from COVID-19

More from Scrip